Novavax’s Novel Matrix-M™ Adjuvant Technology is Key Component of Oxford Malaria Vaccine

April 17, 2023

Novavax’s Matrix-M™ adjuvant is being used in Oxford University’s R21/Matrix-M™ malaria vaccine. The malaria vaccine recently received its first authorizations in Ghana and Nigeria and was announced in a joint press release by Oxford, Serum Institute of India and Novavax.